Return on Assets: An indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets. Calculated as: Income from Continuing Operations / Total Assets
Jasper Therapeutics, Inc. (JSPR) had Return on Assets of -67.94% for the most recently reported fiscal year, ending 2023-12-31.
| Income Statement Financials | |
-- |
|
$-64.47M |
|
-- |
|
-- |
|
$68.86M |
|
$-68.86M |
|
$4.40M |
|
$-64.47M |
|
$-64.47M |
|
$-64.47M |
|
$-64.47M |
|
$-64.47M |
|
$-64.47M |
|
$-68.86M |
|
$-67.75M |
|
10.44M |
|
10.44M |
|
$-6.18 |
|
$-6.18 |
|
| Balance Sheet Financials | |
$88.94M |
|
$2.73M |
|
$5.95M |
|
$94.89M |
|
$12.37M |
|
-- |
|
$4.08M |
|
$16.45M |
|
$78.44M |
|
$78.44M |
|
$78.44M |
|
11.16M |
|
| Cash Flow Statement Financials | |
$-52.07M |
|
$-0.27M |
|
$100.97M |
|
$38.67M |
|
$87.30M |
|
$48.64M |
|
$5.21M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
7.19 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-52.33M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-82.18% |
|
-82.18% |
|
|
Return on Assets |
-67.94% |
-82.18% |
|
$7.03 |
|
$-5.01 |
|
$-4.99 |
|